Head of Oncology Biostatistics Disease Unit, Stevenage
Client:
GSK Location:
Job Category:
Other EU work permit required:
Yes Job Reference:
626370e16e6a Job Views:
10 Posted:
22.01.2025 Expiry Date:
08.03.2025 Job Description:
Job description Site Name:
UK - Hertfordshire - Stevenage, USA - Pennsylvania - Upper Providence, Waltham Posted Date:
Jan 15 2025
GSK Oncology has a commitment to the discovery and development of new oncology therapies with the life-changing potential of helping patients with cancer. Are you a strategic, collaborative and visionary leader? In this critical and highly visible role, the Disease Unit Head of Oncology Statistics will provide statistical leadership in planning and implementing disease area strategy across oncology assets in multiple tumor indications in order to deliver clearly differentiated medicines to our patients. You will partner with cross-functional counterparts to fully understand the strategic objectives, science and rationale of novel oncology targets with various pathways. Leveraging your statistical expertise, you will identify the opportunities to implement or apply novel statistical methodology and establish the reputation both domestically and internationally as a thought leader in statistics. You will also be a people leader who is able to build, lead and develop a team of statistical experts. Key Responsibilities:
The responsibilities listed below outline the scope of the position. The application of these tasks may vary, based upon evolving business needs. Set and lead the biostatistical strategy and technical expertise for select tumor indications in the disease unit, including opportunities for innovation and continuous improvement. Partner with cross-functional counterparts to understand and align the strategic objectives of assets and potential opportunities for drug combinations. Build a matrix team of statisticians to support clinical development in novel assets, with the appetite for innovation, development of technical capabilities, as well as behavioral and communication skills to meet the objectives. Understand and educate the biostatistics organization about the science and rationale behind the novel oncology assets with various newly identified targets. Drive the quantitative decision-making principles/process to inform smart risk-taking drug development. Contribute to and influence the strategic direction of the asset development and regulatory submission via rigorous and robust statistical knowledge. Ensure state-of-the-art expertise on all methodological aspects of drug development in statistics. Partner with counterparts in the Programming organization to ensure high-quality execution of all trial analyses and submissions, planning the resource strategy, with accountability for budget, quality and CRO oversight. Prioritize the acquisition, retention and development of key talents. Serve as a member of the Oncology Biostatistics Leadership Team. Basic Qualifications
PhD Degree in Statistics or closely related field. Extensive experience in the pharmaceutical industry. Strong experience supporting oncology from a statistical perspective. Strong experience as a people leader. Knowledge/understanding of drug development process through commercialization. Preferred Qualifications
Expertise in a wide range of novel or emerging statistical methodology and the clinical/regulatory knowledge across different tumor types in the oncology research. Demonstrate ability to drive and influence oncology strategic direction. Exceptional capability to influence leadership. Familiarity with regulatory interactions and pathways. Adept at embedding talent management throughout the team, providing constructive feedback to enable team members to perform to their optimum, and creating and leading an empowered, motivated team where diversity of thought is encouraged. Track record of strong statistical contributions and accomplishments in clinical drug development, with a broad knowledge of all phases of drug development (pre-clinical; Phase I-IV). Demonstrate ability to lead or make major contributions to department, organizational and/or industry-wide initiatives, through effective communication and influence. Demonstrate exceptional strategic and statistical thinking ability.
#J-18808-Ljbffr
Client:
GSK Location:
Job Category:
Other EU work permit required:
Yes Job Reference:
626370e16e6a Job Views:
10 Posted:
22.01.2025 Expiry Date:
08.03.2025 Job Description:
Job description Site Name:
UK - Hertfordshire - Stevenage, USA - Pennsylvania - Upper Providence, Waltham Posted Date:
Jan 15 2025
GSK Oncology has a commitment to the discovery and development of new oncology therapies with the life-changing potential of helping patients with cancer. Are you a strategic, collaborative and visionary leader? In this critical and highly visible role, the Disease Unit Head of Oncology Statistics will provide statistical leadership in planning and implementing disease area strategy across oncology assets in multiple tumor indications in order to deliver clearly differentiated medicines to our patients. You will partner with cross-functional counterparts to fully understand the strategic objectives, science and rationale of novel oncology targets with various pathways. Leveraging your statistical expertise, you will identify the opportunities to implement or apply novel statistical methodology and establish the reputation both domestically and internationally as a thought leader in statistics. You will also be a people leader who is able to build, lead and develop a team of statistical experts. Key Responsibilities:
The responsibilities listed below outline the scope of the position. The application of these tasks may vary, based upon evolving business needs. Set and lead the biostatistical strategy and technical expertise for select tumor indications in the disease unit, including opportunities for innovation and continuous improvement. Partner with cross-functional counterparts to understand and align the strategic objectives of assets and potential opportunities for drug combinations. Build a matrix team of statisticians to support clinical development in novel assets, with the appetite for innovation, development of technical capabilities, as well as behavioral and communication skills to meet the objectives. Understand and educate the biostatistics organization about the science and rationale behind the novel oncology assets with various newly identified targets. Drive the quantitative decision-making principles/process to inform smart risk-taking drug development. Contribute to and influence the strategic direction of the asset development and regulatory submission via rigorous and robust statistical knowledge. Ensure state-of-the-art expertise on all methodological aspects of drug development in statistics. Partner with counterparts in the Programming organization to ensure high-quality execution of all trial analyses and submissions, planning the resource strategy, with accountability for budget, quality and CRO oversight. Prioritize the acquisition, retention and development of key talents. Serve as a member of the Oncology Biostatistics Leadership Team. Basic Qualifications
PhD Degree in Statistics or closely related field. Extensive experience in the pharmaceutical industry. Strong experience supporting oncology from a statistical perspective. Strong experience as a people leader. Knowledge/understanding of drug development process through commercialization. Preferred Qualifications
Expertise in a wide range of novel or emerging statistical methodology and the clinical/regulatory knowledge across different tumor types in the oncology research. Demonstrate ability to drive and influence oncology strategic direction. Exceptional capability to influence leadership. Familiarity with regulatory interactions and pathways. Adept at embedding talent management throughout the team, providing constructive feedback to enable team members to perform to their optimum, and creating and leading an empowered, motivated team where diversity of thought is encouraged. Track record of strong statistical contributions and accomplishments in clinical drug development, with a broad knowledge of all phases of drug development (pre-clinical; Phase I-IV). Demonstrate ability to lead or make major contributions to department, organizational and/or industry-wide initiatives, through effective communication and influence. Demonstrate exceptional strategic and statistical thinking ability.
#J-18808-Ljbffr
